REG - Active Energy Group - Total Voting Rights

Active EnergyAnnouncement

30/04/2020 07:01

RNS Number : 3288L
  
Active Energy Group PLC
  
30 April 2020
  
 

30 April 2020
Active Energy Group Plc
('Active Energy', 'AEG' or the 'Company')
 Total Voting Rights 
Active Energy, the London quoted international biomass based renewable energy business, announces that the total issued share capital of the Company consists of 1,273,539,063 ordinary shares of 1 pence each.
This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
ENDS
Enquiries:




Website


LinkedIn


 




www.aegplc.com


www.linkedin.com/company/activeenergy
 


 




 




Enquiries




Active Energy Group Plc


Michael Rowan
Chief Executive Officer
Antonio Esposito
Chief Operations Officer


 




SP Angel Corporate Finance LLP
Nominated Adviser and Broker
 


David Hignell / Caroline Rowe


Office: +44 (0)20 3470 0470




Camarco
Financial PR Adviser


Gordon Poole / Tom Huddart / Emily Hall


aeg@camarco.co.uk
Office: +44 (0) 20 3757 4980




About Active Energy Group:
Active Energy Group plc is a London listed (AIM: AEG) renewable energy company that has developed a proprietary technology which transforms low-cost biomass material into high-value green fuels.  Its patented product CoalSwitch™ is the world's only drop-in biomass fuel that can be mixed at any ratio with coal or completely replace coal in existing coal-fired power stations without requiring plant modification. Active Energy Group's immediate strategic focus is the production and commercialisation of CoalSwitch™ and a low emission CoalSwitch™ blend that utilises other waste materials.
 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
TVRPPUCPCUPUGUB